Skip to content

News and stories

Follow the latest releases and stories from Orion and find links to media contacts, image bank and more.

Stock exchange releases

All releases 

Press releases

7/3/2026 Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
6/30/2026 Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market
6/23/2026 Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission
5/30/2026 Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours

All releases 

Subscribe to releases

Subscribe Orion Corporation's stock exchange and press releases to your e-mail.

Subscribe

Orion Pharma content bank

You can find and download Orion Pharma brand images and assets such as logos in the public content bank.

Visit content bank

Content themes

Corporate Communications contacts

Media

Please note that we only respond to media inquiries.

media@orionpharma.com

+358509662244
Christina Weber-Villumsen

Vice President, Corporate Communications, Brand and Public Affairs

christina.weber-villumsen@orionpharma.com

+358504635247
Mari Lautsuo

Communications Manager

mari.lautsuo@orionpharma.com

+358104262156
Valtteri Manninen

Communications Manager

valtteri.manninen@orionpharma.com

+358509662303
Verna Vuorinen

Communications & Brand Manager

verna.vuorinen@orionpharma.com

+358104262211
Samuli Koski

Communications Coordinator

samuli.koski@orionpharma.com

+358509663168

Disclosure policy

In its communications, Orion Corporation complies with valid legislation, the rules and insider guidelines of Nasdaq Helsinki Ltd, the regulations and guidelines of the Financial Supervisory Authority and the instructions and principles defined internally in the company.